Abstract
Background Platelet-monocyte (PMA) and platelet-neutrophil aggregations (PNA) are critical in causing acute inflammatory reactions favoring vascular dysfunction. However, the precise pathophysiological link between Platelet-leukocyte aggregates and Vascular Dementia (VaD) remains undetermined. Our study aimed to investigate whether platelet hyperresponsiveness is independently associated with a predictor of VaD.
Methods Platelet from 19 VaD patients and 18 age-matched healthy controls were subjected to different investigations.
Result PMA, PNA, P-selectin externalization, and intracellular free Ca+2 ([Ca+2i]) flux were evaluated either in whole blood or in platelet-rich plasma. The result revealed that PMA, PNA, P-selectin, and [Ca+2]i were found to be significantly outnumbered in the VaD group (4.1, 2.8, 2.7, and 2.5 times higher) compared to the control group with p-value <0.001, <0.001, <0.001, and 0.001 at 95% CI = 31.164 to 54.855, 8.653 to 22.793, 35.064 to 94.369 and 8747.015 to 28829.618 respectively.
Conclusion Patients with Vascular Dementia have increased platelet leucocyte interaction, and PMA has the most significant prediction of vascular dementia than in subjects of healthy control. Thus, platelets in VaD patients switch to a ‘hyperactive’ phenotype.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by IOE (Institution of Eminence) Banaras Hindu University. IOE Grant number: 42872.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study protocol was reviewed and approved by Institutional Ethics Committee, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data generated or analysed during this study are included in this article and its supplementary material file.
